Please login to the form below

Not currently logged in
Email:
Password:

MHRA upholds Lundbeck complaint

The Medicines and Healthcare products Regulatory Agency has upheld a complaint against Lundbeck UK. 

The Medicines and Healthcare products Regulatory Agency (MHRA) has upheld a complaint against Lundbeck UK. 

A complaint was made to the MHRA that a website containing information on the product Serdolect, was linked to from the Lundbeck UK company website although it is not currently marketed in the UK and allowed open-access to promotional information for healthcare professionals.

Lundbeck stated that they did not intend to promote to a UK audience and removed the unintended link from the UK website. 
 
 

22nd January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics